Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Subcontract opportunity from Department Of Defense was posted on December 5, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Clinical Trial Management for Plasmodium vivax Malaria Study (Thailand Site)

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

This subcontract, issued by the Army Medical Resources Acq Activity under the Department of Defense, involves the full management of a clinical trial based in Thailand. The primary objective of the study is to assess the efficacy of tafenquine as a radical cure for Plasmodium vivax malaria. The scope of work encompasses all critical operational phases, including subject recruitment, Institutional Review Board submissions, drug administration, rigorous safety monitoring, and comprehensive data collection. The opportunity was posted on December 5, 2025, with a response deadline of December 11, 2025. Classified under NAICS code 541711, the contract focuses on specialized research and development. While the trial activities are centered in Thailand, the place of performance is associated with Silver Spring.

General Info

NAICS

541711 - Research and Development in Biotechnology

Place of Performance

Silver Spring, MD, 20910, USA

Set-Aside

NONE

Documents

This scope was carved out of HT942526Q0025.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Water For Injection (WFI) System Pump repair/replacement and Emergency Services

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Army Medical Resources Acq Activity
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Full management of a clinical trial in Thailand to assess tafenquine’s efficacy as a radical cure for P. vivax malaria, including subject recruitment, IRB submissions, drug administration, safety monitoring, and data collection.

More opportunities from Department Of Defense → Army Medical Resources Acq Activity

Same awarding agency

NAICS: 813920
Federal
Biomedical Research Application Evaluation and Support (BRAES)
Solicitation # HT942727RE006
The Biomedical Research Application Evaluation and Support (BRAES) contract is a performance-based, non-commercial Multiple Award Indefinite Delivery Indefinite Quantity (MA-IDIQ) solicitation issued by the Defense Health Agency for the Congressionally Directed Medical Research Programs. With a ceiling cost of 137 million dollars and an estimated period of performance from January 2027 to January 2032, the contract supports the evaluation of biomedical research applications. The scope is divided into four primary areas: funding opportunity announcement set-up, oversight of application receipt and processing, application compliance review, and scientific merit peer review. While the first three tasks are awarded to a single vendor via the eBRAP task order, the scientific peer review tasks are awarded to multiple vendors through Science Administration and Management (SAM) task orders, which require the operation of a secure, contractor-owned, contractor-operated (COCO) web-based system. The government will utilize a Highest Technically Rated with a Fair and Reasonable Cost/Price approach to select approximately three awardees. Evaluation factors include technical approach, management approach, past performance, and small business participation, with cost and price serving as the final check for the highest-rated proposals. Key requirements for offerors include an active SAM registration, a CMMC Level 1 self-assessment, and the submission of a five-volume proposal by December 2, 2026. Contract administration involves a mix of Cost Plus Fixed Fee and Firm Fixed Price arrangements, with invoicing processed through the Wide Area Workflow system. Performance is monitored via Quality Assurance Surveillance Plans using random sampling and 100 percent inspection to determine CPARS ratings based on accuracy and schedule adherence.
Professional Organizations

POSTED

26 days ago

DEADLINE

in 18 days
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS